CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors
Publication
, Conference
Logan, K; Huang, J; Morse, M; Shi, C
Published in: LABORATORY INVESTIGATION
2022
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2022
Volume
102
Issue
SUPPL 1
Start / End Page
488 / 489
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Logan, K., Huang, J., Morse, M., & Shi, C. (2022). CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. In LABORATORY INVESTIGATION (Vol. 102, pp. 488–489).
Logan, Kristen, Jiaoti Huang, Michael Morse, and Chanjuan Shi. “CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors.” In LABORATORY INVESTIGATION, 102:488–89, 2022.
Logan K, Huang J, Morse M, Shi C. CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. In: LABORATORY INVESTIGATION. 2022. p. 488–9.
Logan, Kristen, et al. “CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors.” LABORATORY INVESTIGATION, vol. 102, no. SUPPL 1, 2022, pp. 488–89.
Logan K, Huang J, Morse M, Shi C. CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. LABORATORY INVESTIGATION. 2022. p. 488–489.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2022
Volume
102
Issue
SUPPL 1
Start / End Page
488 / 489
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences